Bharat Biotech has teamed up with Alopexx Inc to co-develop and market the broad-spectrum antimicrobial vaccine AV0328 in India and other low-income areas. The vaccine targets poly N-acetyl glucosamine found on various pathogens. Pre-clinical studies showed its effectiveness against over 15 pathogens, and a phase I trial confirmed its safety.
Related Posts
Baba Kalyani’s sister challenges validity of mom’s wills in court
Sugandha Hiremath, sister of Bharat Forge chairman Baba Kalyani, has challenged the validity of her late mother’s two wills in a Pune court. She alleges […]
‘India is somewhat insulated…’: Fitch sees India GDP growth at 6.5% in FY26 amidst US tariff policies
- staff
- March 19, 2025
- 0
India’s economy is expected to grow 6.5% in FY26, slightly slowing in FY27 to 6.3%. Fitch highlights India’s relative insulation from US trade policies due […]
Zhang Yiming, TikTok billionaire, is now China’s richest person – all you want to know about him
- staff
- March 27, 2025
- 0
Zhang Yiming, the founder of ByteDance, has become the wealthiest person in China with a net worth of $57.5 billion. This achievement is particularly noteworthy […]